top
Search terms
Results 1 - 1 of 1 - ordered by :
Ehjcardiovascrec

Background: Azimilide, a new class III drug, was initially believed to be a highly selective blocker of the slow delayed rectifier (IKs), but recent studies suggest that azimilide potently blocks ...

Cardiovascular Research, Original Article, Stanley Nattel, Lili Liu, Dalie St-Georges

Date : 01/03/1998